Prilenia Neurotherapeutics Ltd.

Spyridon Papapetropoulos

Beth E Borowsky

Michael Hayden

Eli Eyal

Juha-Matti Savola

Igor D Grachev

Mark Forrest Gordon

The invention provides a method of treating a subject afflicted with a dystonia, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to treat the subject.

Use of pridopidine for treating dystonias

This invention provides a method of maintaining functional capacity, improving functional capacity, or lessening the decline of functional capacity in a human patient comprising periodically orally administering to the patient a pharmaceutical composition comprising pridopidine such that a dose of 90-225 mg of pridopidine is administered to the patient per day, so as to thereby maintain functional capacity, improve functional capacity, or lessen the decline of functional capacity in the human patient.

Use of pridopidine for treating functional decline

Growing community of inventors

Wellesley Hills, MA, United States of America

Spyridon Papapetropoulos